This Capital Enterprise programme seeks to support the worlds leading Precision Medicine startups through development, regulation, investment, adoption and scale to UK and international markets.

The programme curates specialist support for precision medicine innovations, allowing startups to develop research into world-leading technology, gain support for regulatory approval and adoption and to access a curated incubator space.